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Infectious bursal disease (IBD) is a highly contagious viral disease of poultry with huge 
economic consequences. First reported in Nigeria in 1973, the disease has since become endemic 
across the country. Inspite of routine vaccine administration, outbreaks are frequently reported in 
vaccinated flocks which questions the effectiveness of the vaccine to confer adequate protection 
against the circulating strains of the virus. In this study, suspected IBD outbreaks from 9 poultry 
farms spanning 2015 – 2016 were investigated. The hypervariable region (HVR) of the VP2 
gene of infectious bursal disease virus (IBDV) from these outbreaks was sequenced. Based on 
the phylogenetic tree and deduced amino acid sequences, the viruses clustered with African very 
virulent (vv) types (VV2-1) with markers typical for vvIBDV at positions 222A, 242I, 256I, 294I 
and 299S. Also, unique substitutions were identified at the hydrophilic peak A (215Q→P) and 
minor peak 2 (280N→Y) in addition to that previously unreported at position 308I→L. These 
results demonstrate continuous circulation and mutations at the HVR of the VP2 which 
underscores the need for constant monitoring of IBDV in Nigerian poultry. Further study is 
required to establish the biological function(s) of these mutations on the pathogenicity and 
antigenicity of the virus. 
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INTRODUCTION 
Since its discovery by Cosgrove (1962), 
infectious bursal disease (IBD), caused by 
infectious bursal disease virus (IBDV), has 
continued to plague the poultry industry 
worldwide. The disease is acute, highly 
contagious and affects chickens aged 3-6 
weeks, causing severe immunosuppression 
in infected chickens below 3 weeks of age 
(Chakman, 2015). Though, evidences of 
outbreaks in older chickens have been 
documented (Okoye and Uzoukwu, 1981; 
Shekaro and Josiah, 2015). The organ in 
chickens targeted by IBDV is the bursa of 
Fabricius where it causes a depletion of the 
B-lymphocytes (Silva et al., 2016). The 
causative agent is a member of the genus 
Avibirnavirus of the family Birnaviridae 
(Delmas et al., 2012). In nature, only two 




serotypes of IBDV are known thus far. The 
first, serotype 1 is pathogenic in chicken 
while the second, serotype 2 is apathogenic 
in chickens (Lasher and Shane, 1994). 
Infectious bursal disease virus (IBDV) is a 
non-enveloped, icosahedral bi-segmented 
RNA virus, with the larger genome segment 
A (3.3kb) containing two overlapping open 
reading frames (ORF). A nonstructural 
protein, VP5, is encoded by the first ORF, 
while the second ORF encodes a polyprotein 
that is cleaved proteolytically to produce the 
viral capsid protein (VP2), 
ribonucleoprotein (VP3) and viral protease 
(VP4). Though smaller in size (2.8kb), the 
second genome segment B encodes a single 
ORF VP1, an RNA-dependent RNA 
polymerase (van den Berg, 2000).  
Since it was first described in Nigeria in 
1973 (Ojo et al., 1973), IBD has ravaged 
and still continues to wreck havoc on the 
poultry industry in Nigeria, which has made 
it achieve an endemic status. There have 
been several reports of outbreaks of IBD in 
both vaccinated and unvaccinated poultry 
chickens in Nigeria (Adamu et al., 2013; 
Luka et al., 2014; Owolodun et al., 2015; 
Nwagbo et al., 2016). Previous and recent 
studies have implicated very virulent (vv) 
strains of IBD as being responsible for these 
outbreaks (Owoade et al., 2004; Adamu et 
al., 2013; Luka et al., 2014; Owolodun et 
al., 2015; Nwagbo et al., 2016). In addition, 
a very recent study also implicated 
reassortant IBDV strains as contributing to 
the failure of IBD vaccine in protecting 
chickens against field IBDV infection in 
Nigeria (Nwagbo et al., 2016). The frequent 
and relentless outbreaks of IBD, especially 
in vaccinated poultry flocks have made it 
mandatory for regular epidemiological 
studies to be carried out in order to keep 
track of any genetic changes/variations that 
may occur in the field. This will enhance the 
efforts in controlling IBD in Nigeria and 
also assist in the selection of the right 
vaccine strain that will be effective in 
combating IBD outbreaks in the field. In this 
study, 9 field IBDV isolates obtained from 
commercial broiler and pullet poultry farms 
from two states in Nigeria covering 2015 to 
2016 were characterized to ascertain the 
strain(s) responsible for the outbreaks and 
also to determine if there are any genetic 
changes or variations. 
 
MATERIAL AND METHODS 
At postmortem, a total of 9 bursae of 
Fabricius were collected from dead chickens 
from IBD suspected cases submitted to the 
Diagnostic division of the National 
Veterinary Research Institute, Vom, Nigeria. 
The clinical history and description of the 
samples are shown in Table I. 
To test for the presence of IBDV antigen, all 
the samples were processed and tested by 
standard procedure (OIE, 2008). Briefly, 
20% (w/v) bursae homogenates from the 
individual outbreaks were prepared and agar 
gel immunodiffusion (AGID) test conducted 
accordingly.  In addition, viral RNA was 
extracted from the bursae homogenates 
using the QIAamp Viral RNA Mini Kit 
(Qiagen®, Hilden, Germany) according to 
manufacturer’s instructions. Primers (F: 5´-
GCCCAGAGTCTACACCAT-3´ and R: 5´-
CCCGGATTATGTCTTTGA-3´) that 
amplifies a 743bp fragment of the VP2 
region of genome segment A was used 
(Jackwood and Sommer-Wagner, 2005). 
Using TitanOne RT-PCR kit (Roche, 
Germany), One-step RT-PCR was 
performed with the following cycling 
condition:  42
o
C for 30mins and 95
o
C for 
2mins followed by 35 cycles of PCR at 95
o
C 
for 30 secs, 55
o
C for 1:30 mins and 72
o
C for 
2 mins. After completion of the 35 cycles, a 
final extension at 72
o
C for 7mins was 
performed. To analyse the PCR products, it 
was separated using 1.5% agarose gel 
stained with ethidium bromide (0.5mg/mL) 
and the bands visualized on gel 
documentation system (BioStep, Germany). 
The amplicons were purified using the 
QIAquick PCR Purification kit (Qiagen, 
Germany). To sequence the purified 





TABLE I: Description of the field IBDV samples used in this study 


















































Kuru, Plateau 4 Broiler
s 
































  VV2-1 
ND- No data; 1
st




 – two doses of IBD vaccine given; 
VV – very virulent 
  
amplicons, the two primers used in the RT-
PCR amplification were used in both 
forward and reverse directions by a 
commercial sequencing service provider 
(Macrogen® Inc., Korea) on an ABI 
3730XL genetic analyzer machine. The 
Consensus nucleotide sequence was 
generated for each sample from the two 
primer set sequences using BioEdit. 
Alignment of the nucleotide and amino acid 
sequences including the construction of 
phylogenetic tree was carried out using 
MEGA v7.0 (Kumar et al., 2016). The 9 
nucleotide sequences generated in this study 
have been deposited to the GenBank under 
the accession numbers: MG190860 – 
MG190868. 
 
RESULTS AND DISCUSSION 
All the nine bursae sample tested positive 
for IBDV antigen both by AGID and the 
amplification of a 743bp fragment of the 
VP2 gene. Also, comparison of the 
nucleotide sequences of the 9 IBD viruses 
with reference vvIBDV UK661 and variant 
Del E, showed nucleotide identities that 
ranged from 96.5% to 97.2% and 93.5% to 
94.3% respectively. When compared with 
each other, the nucleotide sequences of the 9 
IBD viruses showed an identity that ranged 
from 97.2% to 100%. In comparison with 
some previously published Nigerian IBDV, 
nucleotide identities ranged from 94% to 
99.9% with none of them having a 100% 
match.   
Amino acid sequences deduced from the 
nucleotide sequences of the hvVP2 region of 
the nine viruses from aa 210 – 442 revealed 
amino acids consistent with vvIBDV at 
positions 222A, 242I, 256I, 294I and 299S. 
Comparison of the amino acid sequences of 
the nine viruses from position 211 – 353 
with reference vvIBDV UK661, OKYM, 
HK46, variant IBDV Del E, some 
previously published Nigerian IBDV and 
African IBDVs showed amino acid 




substitutions in 3 out of the 9 viruses studied 
at aa positions 215Q→P (IBD-
NG513/2016), 280N→Y 
TABLE II: Comparison of genome segment A amino acids substitutions at selected positions between the 
recent Nigerian IBD viruses and other published IBD viruses from the GenBank 

















299 300 308 
UK661 Q Q A I I G T I A N S E I 
IBD-NG899/2015 . . . . . S . . . . . A . 
IBD-NG499/2016 . . . . . S . . . . . A . 
IBD-NG511/2016 . . . . . S . . . . . A . 
IBD-NG516/2016 . . . . . S . . . . . A . 
IBD-NG513/2016 P . . . . S . . . . . A . 
IBD-NG580/2016 . . . . . S . . . . . A . 
IBD-NG587/2016 . . . V . S . . . . . A L 
IBD-NG590/2016 . . . . . S . . . Y . A . 
IBD-NG592/2016 . . . . . S S . . . . A . 
KP266324_BAUCHI58/NG/20
12 
. T . . . S S . . . . Q . 
KP266333_PLATEAU78/NG/2
011/1 
. T . . . S . . . . . Q . 
KP152258_UYO201/NG/2014 . . . . . S . . . . . A . 
KP152270_BENIN142E/NG/20
13 
. . . . . . . T N . . . . 
KP152271_ABUJA93/NG/201
3 
. . . . . S . . . . . A . 
JX424059.1_IBDV33/Abuja.N
G/2011 
. . . . . S . . . . . A . 
JX424070.1_IBDV63/Kaduna.
NG/2009 
. . . . . S . . . . . A . 
AJ586955.1_IBDV/Oyo.NIE/9
9/015/c 
. . . . . S . . . . .  . 
AJ586939.1_IBDV/Oyo.NIE/9
7/102/c 
. . . . . S . . . . . A . 
AJ586951.1_IBDV/Oyo.NIE/9
8/058/ 
. . . . . . . . . . .  . 
AJ586924.1_IBDV/Osun.NIE/9
6/076/c 
. . . . . . . . . . . A . 
EF363551.1_Bk H . . . . S . . . . .  . 
AJ001941.1_88180_IVORY_C
OAST 
. . . . .  . . . . . Q . 
KM870811_BF36-9 . . . . . S . . . . . A . 
HQ231797.1_86-2006Eth . . . . . S . . . . . Q . 
AB200982_KMRG-
40_Tanzania 
. . . . . S . . . . . A . 
A dot indicates identical sequences 
  
(IBD-NG590/2016), and 308I→L (IBD-
NG587/2016) (Table II). Two of the 
observed mutations occurred at major peak 
A loop PBC (aa 215) and minor peak 2 loop 
PFG (aa 280) respectively while the third 
mutation occurred outside the loop at aa 




position 308 (Table II). As previously 
reported, amino acid changes occurring in 
the hydrophilic peaks can cause an antigenic 
drift (Jackwood and Sommer-Wagner, 
2011). It is well 
 
FIGURE I: Phylogenetic analysis of the nucleotide sequences of the hvVP2 of IBDV used in 
this study with reference IBDV from GenBank using the neighbor joining method with 1000 
bootstrap replication. IBD viruses used in this study are identified by shaded circles and 
reference strains are identified by GenBank accession number followed by name. Scale bar 
represent substitution per site 
 
documented that viruses especially RNA 
viruses which are error-prone use the 
mechanism of mutation to escape 
neutralization by vaccines which ensures 




their continuous survival (Pikula et al., 
2017). Likewise, the bi-segmented nature of 
IBDV encourages the sharing and exchange 
of genetic materials between the two 
segments of IBDV thereby giving rise to 
homologous recombination and reassortant 
IBDV strains which favors variation of 
IBDV in nature (Qin and Zheng, 2017). 
Sequence analysis of the VP2 region 
spanning from aa positions 206 – 350 have 
been used for molecular characterization of 
IBDV by Wu et al. (2007). This region is 
the hot zone for mutation, tissue culture 
adaptation and viral virulence (Brandt et al., 
2001). Comparison of the nine viruses and 
previously published Nigerian IBDV from 
GenBank showed that this mutation was 
unique to the 3 samples. A previous 
Nigerian IBDV isolate (EF363551.1_BK) 
had mutation Q→H at position 215 but in 
this study, amino acid in this position was 
substituted with a P (proline). Amino acid 
position 215 of Nigerian IBDV have 
undergone two successive mutations so far 
from Glutamine (polar) in UK661 to 
Histidine (basic polar) and Proline 
(nonpolar). As reported by Mohamed et al. 
(2014), changes in the charges on the amino 
acids may affect the topography of the 
epitopes on the VP2 responsible for 
neutralization which can lead to vaccination 
failure. Further comparison of the nine 
viruses with some IBDV and reference 
IBDV from GenBank showed these 
mutations were unique to the recent IBDV 
from Nigeria (data not shown). 
A phylogenetic tree constructed based on the 
nucleotide sequences comprising of the nine 
recent Nigerian isolates, previous Nigerian 
IBDV, IBDV from some African countries, 
vaccine strain, variant and reference 
vvIBDV showed three major clusters; very 
virulent, variant and vaccine. The nine 
isolates used in this study were found in the 
first cluster that comprised of vvIBDVs but 
6 out of 9 formed a unique cluster with a 
previous Nigeria IBD virus (KP152271 
ABUJA93/NG/2013) and sub clusters of 
their own within the group (Figure I). Very 
virulent IBD viruses in the African continent 
are divided into three; VV1, VV2 and VV3. 
VV1 consists of IBD viruses from Ethiopia, 
Nigeria and Zambia, for VV2, IBDV from 
Nigeria, Tanzania, Zambia and recently 
Senegal while VV3 consists of IBDV from 
Africa, Asia, Europe, South America and 
others (Nwagbo et al., 2016; Badji et al., 
2016). On the tree, the nine viruses clustered 
with the African very virulent type VV2 
specifically in the VV2-1 lineage (Figure I). 
The VV2-1 lineage was unique to IBD 
viruses from Nigeria but has recently been 
joined by IBDV from Senegal. Grouping of 
IBDV in Africa into lineages and 
sublineages has helped to further elucidate 
the genetic relatedness and or divergence of 
African IBDV strains from one country to 
another thereby showing the dynamics of 
IBDV in Africa.
In conclusion, this study has further 
implicated the very virulent strain of 
infectious bursal disease virus as the cause 
of the outbreaks being experienced in 
vaccinated poultry flocks in Nigeria and also 
reflects the continuing genetic instability of 
IBD virus in the country. In view of this 
report, urgent review of the vaccination 
strategy is recommended to curb the 
incessant outbreak of IBDV in Nigeria. 
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